other

Updated:

IQVIA

IQVIA offers clinical research services, commercial insights, and healthcare intelligence. The company provides services such as clinical trial optimization,...

IQVIA

IQVIA offers clinical research services, commercial insights, and healthcare intelligence. The company provides services such as clinical trial optimization, real-world evidence generation, and commercialization of medical treatments, supported by analytics and AI technology. IQVIA serves sectors including biotechnology, medical devices, pharmaceuticals, and other healthcare stakeholders, and is based in Durham, North Carolina.

General information

Firm type

other

Location

Region

North America

Country

United States

City

Danbury

Corporate office

Danbury, CT, United States

Sector focus

Healthcare ServicesEnterprise SoftwareAI/MLDigital Health

Frequently asked questions

Who runs investment decisions at IQVIA?

IQVIA is a publicly traded company (NYSE: IQV) with a board of directors led by CEO Ari Bousbib, who has served since 2016. Investment decisions for capital allocation — including R&D spending, acquisitions, and clinical trial investments — are made by the executive management team under board oversight (per SEC filings, 2025).

Which sectors does IQVIA explicitly focus on?

IQVIA operates exclusively within healthcare — covering pharmaceuticals, biotechnology, medical devices, and diagnostics. It does not service other industries such as finance, energy, or consumer goods (public record).

How does IQVIA source proprietary deal flow?

IQVIA's deal flow comes from its existing biopharma client relationships and the RFP processes for clinical trials. Proprietary data from its patient record database also informs new service offerings and technology development (per company overview, 2024).

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Danbury other profiles